Morgan Stanley’s CeriBell CBLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.41M Buy
344,865
+59,204
+21% +$1.28M ﹤0.01% 3856
2026
Q2
$5.56M Buy
285,661
+54,743
+24% +$1.04M ﹤0.01% 4160
2026
Q1
$4.23M Buy
230,918
+21,250
+10% +$427K ﹤0.01% 4258
2025
Q4
$4.6M Buy
209,668
+55,123
+36% +$855K ﹤0.01% 4243
2025
Q3
$1.78M Buy
154,545
+25,678
+20% +$346K ﹤0.01% 4862
2025
Q2
$2.41M Buy
128,867
+9,876
+8% +$168K ﹤0.01% 4580
2025
Q1
$2.29M Buy
118,991
+50,290
+73% +$1.12M ﹤0.01% 4518
2024
Q4
$1.78M Buy
+68,701
New +$1.87M ﹤0.01% 4791

Other funds holding CBLL

Morgan Stanley's CBLL Position: Q3 2026 in Review

Morgan Stanley increased its CeriBell (CBLL) stake by 21% in Q3 2026, buying an estimated $1.28M and bringing the position to 344,865 shares worth $8.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3856.

Morgan Stanley first reported a position in CBLL in Q4 2024 and has held it in 8 quarters since. 133 funds tracked by Wall St. Rank hold CBLL as of Q3 2026.

  • Morgan Stanley held 344,865 shares of CeriBell worth $8.41M as of Q3 2026.
  • Morgan Stanley bought 59,204 CeriBell shares in Q3 2026, an estimated $1.28M.
  • CeriBell made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #3856 holding.
  • Morgan Stanley first reported a position in CeriBell in Q4 2024 and has held it in 8 quarters since.
  • 133 funds tracked by Wall St. Rank held CeriBell as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.